Back
Integral exits Medima Health to Ardian-backed Simago
19 November 2026

Integral Capital Group (“Integral”) the Central and South-Eastern European mid-market private equity firm, has sold a majority of its stake in Medima Health (“Medima”), a national network of diagnostic imaging clinics in Romania, to Ardian-backed Simago, one of Europe’s leading medical imaging consolidators. Simago acquired its majority stake from Integral, Morphosis Capital Fund I and co-founder Prof. Dr. Gheorghe Iana, following receipt of all required approvals. Co-founder and CEO Vlad Ardeleanu, who has rolled over his entire stake, and the existing management team continue to lead the company.
Integral invested in Medima in November 2022 through Evolving Europe Principal Investments I, alongside Morphosis Capital and the founders. It was the fund’s first investment in Romania. Over the four-year holding period, Medima grew from 9 to 34 MRI, CT and PET-CT clinics and from 8 to 30 cities, opening 23 greenfield clinics, many in cities where advanced imaging was scarce. Acquisitions, in which Integral played a direct, leading role, also supported the network’s expansion. Medima now expects to serve around 200,000 unique patients in 2026, and its 2026 budget envisages revenue of about six times the 2022 level.
Alongside growth capital, including follow-on rounds, Integral helped management turn a founder-led business into an institutional one, introducing professional reporting and budgeting, weekly board oversight, senior hires and a network-wide centralized call center. With Medima, Simago becomes the third-largest medical imaging specialist in Europe and opens its first platform in Central and Eastern Europe.
Romania remains a core market for Integral, which is seeking further partnerships there with high-performing founders to build regional champions. Its Romanian portfolio also includes Embryos Group (IVF) and O’Fresh (vending).
Integral manages institutional private equity and growth capital across two funds and is focused on investments in leading medium- and small-sized companies active in Central and South-Eastern Europe, and the Adria region. Integral’s funds are backed by leading international institutional investors including EIF, EBRD and the International Finance Corporation. Integral covers its pan-regional target market out of hub offices in Budapest and Belgrade, and satellite offices in London, Bucharest, Sofia and Zagreb.
Financial terms of the transaction were not disclosed.
The sellers were advised by Jefferies International as financial advisor and RTPR as lead legal counsel. Vlad Ardeleanu and the Medima management team were advised by CMS.
Integral Capital Group’s investment in Medima through Evolving Europe Principal Investments I benefitted from the financial backing from the European Union under the European Fund for Strategic Investments (EFSI), as well as the Programme for the Competitiveness of Enterprises and small and medium enterprises (COSME) through Equity Facility for Growth (EFG). Medima benefitted from the support of EIF backed by the Government of Romania.



